Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...
Ban the middlemen” has become the easy applause line in healthcare politics. Tennessee’s version is SB 2040, which would ...
Lumos reaches enrolment milestone in a paediatric clinical study assessing use of its FebriDx point of care test, to differentiate ... Read More The post Lumos achieves first enrolment milestone in ...
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a further US$720,000 in non-dilutive funding after completing a key enrolment milestone in its ongoing US paediatric clinical study for ...
Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutes CAMBRIDGESHIRE, UK, 16 February 2026 — LEX Diagnostics, a leading innovator ...
CAMBRIDGE, United Kingdom, Feb. 16, 2026 (GLOBE NEWSWIRE) -- LEX Diagnostics, a leading innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and ...
Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutes CAMBRIDGE, United Kingdom, Feb. 16, 2026 (GLOBE NEWSWIRE) -- LEX Diagnostics ...
LEX Diagnostics, a Cambridgeshire-based innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510 (k) clearance and CLIA waived status for a platform that could ...